We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$10.7B
AUM Growth
+$2.52B
(+31%)
Cap. Flow
+$2.21B
Cap. Flow
% of AUM
20.71%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
1,276
New
389
Increased
311
Reduced
230
Closed
325
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$119M |
| 2 |
Perrigo
PRGO
|
+$108M |
| 3 |
Microsoft
MSFT
|
+$107M |
| 4 |
Zoetis
ZTS
|
+$84.7M |
| 5 |
Viatris
VTRS
|
+$78.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$73.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$66.6M |
| 4 |
Nike
NKE
|
+$57.9M |
| 5 |
AutoZone
AZO
|
+$54.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.92% |
| 2 | Communication Services | 13.85% |
| 3 | Financials | 12.23% |
| 4 | Industrials | 12.2% |
| 5 | Consumer Discretionary | 11.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Hewlett Packard
HPE
$69.4B
| $9.89M | 0.09% |
+1,119,393
| New | +$9.37M |
|
|
ALXN
227
DELISTED
Alexion Pharmaceuticals
ALXN
| $9.87M | 0.09% |
+51,729
| New | +$9.04M |
|
|
FPRX
228
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $9.84M | 0.09% |
237,141
+71,262
| +43% | +$2.39M |
|
229
Burlington
BURL
$23.4B
| $9.8M | 0.09% |
+228,554
| New | +$10.6M |
|
230
Antero Resources
AR
$10.7B
| $9.8M | 0.09% |
+449,628
| New | +$10M |
|
231
Avient
AVNT
$3.91B
| $9.8M | 0.09% |
308,555
+156,451
| +103% | +$5.23M |
|
232
Axalta
AXTA
$8.03B
| $9.71M | 0.09% |
364,546
+25,125
| +7% | +$702K |
|
|
DCH
233
Dauch Corp
DCH
$1.35B
| $9.69M | 0.09% |
+511,738
| New | +$10.8M |
|
234
Simpson Manufacturing
SSD
$7.96B
| $9.67M | 0.09% |
+283,087
| New | +$10.3M |
|
235
Black Hills Corp
BKH
$5.54B
| $9.64M | 0.09% |
207,624
+200,524
| +2,824% | +$8.81M |
|
|
GPOR
236
DELISTED
Gulfport Energy Corp.
GPOR
| $9.61M | 0.09% |
390,960
+355,341
| +998% | +$10M |
|
|
EVHC
237
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $9.58M | 0.09% |
+123,227
| New | +$10.6M |
|
|
STAY
238
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $9.48M | 0.09% |
+596,163
| New | +$10.4M |
|
|
DFT
239
DELISTED
DuPont Fabros Technology Inc.
DFT
| $9.46M | 0.09% |
+297,621
| New | +$9.27M |
|
|
VMW
240
DELISTED
VMware, Inc
VMW
| $9.44M | 0.09% |
166,945
-595,732
| -78% | -$37.1M |
|
|
PXD
241
DELISTED
Pioneer Natural Resource Co.
PXD
| $9.39M | 0.09% |
74,865
-135,931
| -64% | -$18.7M |
|
|
ESL
242
DELISTED
Esterline Technologies
ESL
| $9.38M | 0.09% |
+115,833
| New | +$9.45M |
|
|
ISEE
243
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $9.26M | 0.09% |
117,964
-46,483
| -28% | -$2.69M |
|
244
Digital Realty Trust
DLR
$71.3B
| $9.16M | 0.09% |
121,141
-333,902
| -73% | -$24.1M |
|
245
Manhattan Associates
MANH
$11.1B
| $9.1M | 0.09% |
137,525
+105,307
| +327% | +$7.49M |
|
246
Johnson Controls International
JCI
$93.6B
| $9.03M | 0.08% |
+218,312
| New | +$9.87M |
|
|
CXO
247
DELISTED
CONCHO RESOURCES INC.
CXO
| $8.99M | 0.08% |
96,777
+79,398
| +457% | +$8.5M |
|
|
NS
248
DELISTED
NuStar Energy L.P.
NS
| $8.95M | 0.08% |
223,116
+65,972
| +42% | +$2.85M |
|
249
Tapestry
TPR
$32.7B
| $8.94M | 0.08% |
273,132
+249,066
| +1,035% | +$7.75M |
|
250
Greif
GEF
$5.07B
| $8.91M | 0.08% |
289,115
-137,426
| -32% | -$4.55M |
|
Similar funds
Marshall Wace's Q4 2015 Portfolio in Review
As of Q4 2015, Marshall Wace held 1,276 positions worth $10.7B, up 31% from $8.14B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace deployed $2.21B of net new capital in Q4 2015, opening 389 new positions and adding to 311 existing holdings. Its largest new stake was The Mosaic Company: 1,613,517 shares worth $44.5M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Sherwin-Williams, an estimated $73.7M trimmed.
- Marshall Wace's largest Q4 2015 buy was The Mosaic Company: 1,613,517 shares worth $44.5M.
- Marshall Wace added most to Bristol-Myers Squibb in Q4 2015, an estimated $119M increase.
- Marshall Wace's biggest Q4 2015 reduction was Sherwin-Williams, cutting an estimated $73.7M.
- Marshall Wace fully exited HOME PROPERTIES, INC in Q4 2015, selling an estimated $40.2M.
- Marshall Wace's ten largest holdings make up 17% of its $10.7B portfolio in Q4 2015.
- Marshall Wace opened 389 new positions and closed 325 in Q4 2015.
- Marshall Wace's portfolio value rose 31% quarter-over-quarter to $10.7B.
Based on Marshall Wace's 13F filing for Q4 2015, filed 10 Feb 2016.